Εμφάνιση απλής εγγραφής

dc.creatorNitoda E., Lavaris A., Laios K., Androudi S., Kalogeropoulos C.D., Tsatsos M., Damaskos C., Garmpis N., Moschos M.M.en
dc.date.accessioned2023-01-31T09:40:23Z
dc.date.available2023-01-31T09:40:23Z
dc.date.issued2018
dc.identifier10.21873/invivo.11253
dc.identifier.issn0258851X
dc.identifier.urihttp://hdl.handle.net/11615/77243
dc.description.abstractBackground/Aim: Acute allergic rhinoconjuctivitis is the most common form of ocular allergies. The pathogenetic mechanisms are based on an immunoglobulin E (IgE)-mediated hypersensitivity reaction. On the other hand, tear osmolarity has been suggested to be an index of ocular surface damage and inflammation. These data were the motive to investigate the levels of tear osmolarity in subjects with acute allergic rhinoconjuctivitis, before and after administration of artificial tears. Patients and Methods: Forty-five subjects with acute allergic rhinoconjuctivitis were randomly divided into three groups, based on the type of artificial tears that they received: Group A (Thera tears), Group B (Wet therapy) and Group C (Tears Naturale free). The eye drops were administered six times a day for 60 days and all subjects underwent grading of subjective symptoms and clinical examination at baseline and at the end of the treatment. Results: The diagnosis of severe eye disease, which was based on ocular surface disease index (OSDI; Allergan, Inc, Irvine, CA, USA) and tear osmolarity values, concerned all patients at baseline. Although the administration of artificial tears significantly ameliorated the symptoms and the ocular variables in all groups, the results were better in the first group. Tear osmolarity was strongly and negatively correlated with tear film breakup time (BUT) and Schirmer I test at 2 months. Contrariwise, symptoms were eliminated, when tear osmolarity was decreased. Conclusion: Acute allergic rhinoconjuctivitis is characterized by tear hyperosmolarity, which can be rehabilitated with the administration of hypotonic artificial tears. © 2018 International Institute of Anticancer Research. All Rights Reserved.en
dc.language.isoenen
dc.sourceIn Vivoen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85052194133&doi=10.21873%2finvivo.11253&partnerID=40&md5=5e4ab2fec8c97e8da821b28a019a7e7d
dc.subjectartificial tearen
dc.subjectcalcium ionen
dc.subjecteye dropsen
dc.subjecttears naturaleen
dc.subjectthera tearen
dc.subjectunclassified drugen
dc.subjectadulten
dc.subjectallergic conjunctivitisen
dc.subjectArticleen
dc.subjectclinical articleen
dc.subjectclinical examinationen
dc.subjectcontrolled studyen
dc.subjectdisease severityen
dc.subjectfemaleen
dc.subjecthumanen
dc.subjecthyperosmolarityen
dc.subjectmaleen
dc.subjectOcular Surface Disease Indexen
dc.subjectprospective studyen
dc.subjectrandomized controlled trialen
dc.subjectrhinoconjunctivitisen
dc.subjectSchirmer testen
dc.subjecttear filmen
dc.subjecttear osmolarityen
dc.subjectacute diseaseen
dc.subjectallergic conjunctivitisen
dc.subjectallergic rhinitisen
dc.subjectchemistryen
dc.subjectimmunologyen
dc.subjectlacrimal fluiden
dc.subjectmetabolismen
dc.subjectmiddle ageden
dc.subjectosmolarityen
dc.subjectAcute Diseaseen
dc.subjectAdulten
dc.subjectConjunctivitis, Allergicen
dc.subjectHumansen
dc.subjectMiddle Ageden
dc.subjectOsmolar Concentrationen
dc.subjectRhinitis, Allergicen
dc.subjectTearsen
dc.subjectInternational Institute of Anticancer Researchen
dc.titleTear film osmolarity in subjects with acute allergic rhinoconjunctivitisen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής